Compare NXP Semiconductors N.V. Common Stock (NXPI) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NXP Semiconductors N.V. Common Stock vs Regeneron Pharmaceuticals Inc — how do they compare? NXP Semiconductors N.V. Common Stock trades at $227.52 (market cap $58.27B), while Regeneron Pharmaceuticals Inc trades at $746.54 (market cap $76.14B). The key difference: Regeneron Pharmaceuticals Inc is the larger of the two by market cap, and NXP Semiconductors N.V. Common Stock pays the higher dividend (1.76%). Which is the better fit depends on your goals — on Pluang, investors hold NXP Semiconductors N.V. Common Stock for 0 Days and Regeneron Pharmaceuticals Inc for 107 Days on average.
| NXPI | REGN | |
|---|---|---|
Market Cap | $58.27B | $76.14B |
Volume | 3,950,702 | 500,239 |
Sector | Technology | Health |
52-Week High | $332.67 | $852.03 |
52-Week Low | $184.19 | $557.73 |
Typical Hold Time | 0 Days | 107 Days |
Enterprise Value | $66.38B | $70.85B |
Dividend Yield | 1.76% | 0.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Regeneron Pharmaceuticals (REGN) trades at $739.57, down 0.34% on the day, with a bearish technical signal from moving averages. The company maintains strong fundamentals, including a 27.86% net income margin and consistent earnings beats. Recent news highlights a significant immunology alliance expansion with Sanofi, valued up to $8 billion, which could drive future growth. Cash flow improved in 2025, with net cash flow turning positive at $634.70 million.
The outlook is positive, supported by robust profitability and strategic collaborations, but faces risks from competition in key drug markets and reliance on pipeline success. Analysts are bullish with a consensus price target of $849.84, implying potential upside. Investors should weigh strong financials against execution risks in drug development.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NXP Semiconductors N.V. Common Stock
NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.
Read more on NXPI →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
